A one-week dose-ranging study of inhaled salmeterol in children with asthma

Journal of Asthma

Volumn 34, Issue 1, 1997, Pages 43-52

  Weinstein, Steven ^a   Chervinsky, Paul ^b   Pollard, Stephen J ^b   Bronsky, Edwin A ^c   Nathan, Robert A ^b   Prenner, Bruce ^d   Howland III, William C ^e   Stahl, Edmundo ^f   Liddle, Roger ^f  

^a Medical Group   (United States)

^b AAAA Medical Research Group ^*

^c AAAA Medical Research Group   (United States)

^d Medication Solutions Group   (United States)

^e HealthQuest Research   (United States)

^f GLAXOSMITHKLINE   (United States)

Author keywords

Asthma; Inhalers; Pediatrics; Salmeterol; adrenergic agonists

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; SALBUTAMOL; SALMETEROL XINAFOATE;

ASTHMA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FORCED EXPIRATORY VOLUME; HEADACHE; HOLTER MONITORING; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCHOOL CHILD; SPIROMETRY;

EID: 0031057641     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909709071202     Document Type: Review

References (25)

1. Kemp JP, Bierman CW, Cocchetto DM: Dose-response study of inhaled salmeterol in asthmatic patients with 24-hour spirometry and Holter monitoring. Ann Allergy 70:316 (1993).
2. Bronsky EA, Kemp JP, Orgel HA, et al: A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Chest 105:1032 (1994).
3. Pearlman DS, Chervinsky P, LaForce C, et al: A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 327:1420 (1992).
4. Britton M, Earnshaw JS, Palmer JBD: A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 5:1062 (1992).
5. D'Alonzo GE, Nathan RA, Henochowicz S, Morris RJ, Ratner PR, Rennard, SR: Salmeterol as maintenance therapy compared with regular or as-needed albuterol in patients with asthma. JAMA 271:1412 (1994).
6. Dhillon DP: Studies in exercise-induced asthma. Eur Respir Rev 1:265 (1991).
7. Kemp JP, Dockhorn RJ, Busse WW, Bleecker ER, van As A: Prolonged effect of inhaled salmeterol against exercise-induced bronchospasm. Am J Respir Crit Care Med 150:1612 (1994).
8. Johnson M, Butchers PR, Coleman RA, et al: The pharmacology of salmeterol. Life Sci 52:2131 (1993).
9. 2-adrenoceptor agonist: Comparison with salbutamol in adult asthmatic patients. Thorax 43:674 (1988).
10. Dahl R, Earnshaw JS, Palmer JBD: Salmeterol: A four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 4:1178 (1991).
11. Twentyman OP, Finnerty JP, Harris A, Palmer J, Holgate ST: Protection against allergen-induced asthma by salmeterol. Lancet 336:1338 (1990).
12. Derom EY, Pauwels RA, Van Der Straeten MEF: The effect of inhaled salmeterol on methacholine responsiveness in subject with asthma up to 12 hours. J Allergy Clin Immunol 89:811 (1992).
13. Simons FER, Soni NR, Watson WTA, Becker AB: Bronchodilator and bronchoprotective effects of sal- meterol in young patients with asthma. J Allergy Clin Immunol 90:840 (1992).
14. Verberne AAPH, Hop WCJ, Bos AB, Kerrebijn KF: Effect of a single dose of inhaled salmeterol on baseline airway caliber and methacholine-induced airway obstruction in asthmatic children. J Allergy Clin Immunol 91:127 (1993).
15. Verberne A, Lenney W, Kerrebijn K: A three way crossover study comparing twice daily dosing of salmeterol 25 mcg and 50 mcg with placebo in children with mild to moderate reversible airways disease. Am Rev Respir Dis 143(4, pt 2):A20 (1991).
16. Boner A. Salmeterol: Long-term studies in children. Eur Respir J 5(Suppl 15):318s (1992).
17. Green CP, Price JF: Prevention of exercise induced asthma by inhaled salmeterol xinafoate. Arch Dis Child 67:1014 (1992).
18. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225 (1987).
19. Polgar G, Promadhat V: Pulmonary Function Testing in Children, Techniques and Standards. WB Saunders, Philadelphia, 1971.
20. 1. Eur Respir J 5:975 (1992).
21. National Heart, Lung and Blood Institute: National Asthma Education Program Expert Panel Report. Guidelines for the Diagnosis and Management of Asthma. US Dept of Health and Human Services Publication, NIH 91-3042. Bethesda, MD, 1991.
22. Lenney W: Efficacy and safety of salmeterol in children. Allergy 47:348 (1992).
23. Kemp JP, Furakawa CT, Bronsky EA, et al: Albuterol treatment for children with asthma: A comparison of inhaled powder and aerosol. J Allergy Clin Immunol 83:697 (1989).
24. Wolfe JD, Shapiro GG, Ratner PH: Comparison of albuterol and metaproterenol syrup in the treatment of childhood asthma. Pediatrics 88:312 (1991).
25. Tinkelman DG, Reed CE, Nelson HS, Offord KP: Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 92:64 (1993).